Drug intelligence / Profile preview

5'-triphosphate RNA

Development stage
Preclinical
Lead developer
RIGImmune
Modality
RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intratumoral, Intravenous
01

Overview

5'-triphosphate RNA (5'ppp-RNA or 3pRNA) is a synthetic RNA molecule characterized by a triphosphate moiety at the 5' end, typically in a double-stranded form. It functions as a potent agonist of the retinoic acid-inducible gene I (RIG-I) receptor, a cytosolic pattern recognition receptor that detects viral RNA. Activation of the RIG-I pathway by 5'ppp-RNA triggers a robust innate immune response, characterized by the production of type I interferons and pro-inflammatory cytokines. This biologic modality is being investigated as a cancer immunotherapeutic agent, with research demonstrating its potential to induce immunogenic cell death in tumor cells and enhance CD8+ T cell and natural killer (NK) cell responses. While widely available as a research tool from vendors like InvivoGen, it is also being developed in various proprietary formulations for clinical applications in oncology and infectious diseases.

Other names
5'-triphosphorylated RNAppp-RNA
02

Targets

IFIH1 (MDA5)

Beyond the preview

Go deeper on 5'-triphosphate RNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 5'-triphosphate RNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call